Question 1

What are the potential side effects of ABT-263?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of ABT-263 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia clinical trial (NCT00481091). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of ABT-263 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia clinical trial (NCT00481091). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment schedule look like?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of ABT-263 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia clinical trial (NCT00481091). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits and tests?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of ABT-263 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia clinical trial (NCT00481091). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of ABT-263 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia clinical trial (NCT00481091). Contact the study team or your healthcare provider for specific answers.

Question 6

Is there a chance I could continue treatment after the study ends?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of ABT-263 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia clinical trial (NCT00481091). Contact the study team or your healthcare provider for specific answers.

What this study is about